Abstract
GOAL: The goal of this activity is to educate pharmacists about the use of idarucizumab for the reversal of dabigatran anticoagulant activity. OBJECTIVES: At the completion of this activity, the reader will be able to:1.Describe the pharmacology and pharmacokinetics of idarucizumab.2.Discuss the risks associated with the use of idarucizumab.3.Discuss the potential benefit of idarucizumab for an individual patient.4.Apply the information on the use of idarucizumab to a case study.